tradingkey.logo

Celanese Corp

CE

44.780USD

-0.820-1.80%
Close 09/15, 16:00ETQuotes delayed by 15 min
4.90BMarket Cap
LossP/E TTM

Celanese Corp

44.780

-0.820-1.80%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated2025-09-12

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
38 / 72
Overall Ranking
187 / 4724
Industry
Chemicals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 18 analysts
Hold
Current Rating
54.570
Target Price
+19.67%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Celanese Corporation is a global chemical and specialty materials company. It is a producer of engineered polymers that are used in a variety of applications. Its segments include Engineered Materials and Acetyl Chain. The Engineered Materials segment includes the engineered materials business and certain strategic affiliates. The Engineered Materials business develops, produces and supplies a portfolio of high-performance specialty polymers for automotive and medical applications, as well as industrial products and consumer electronics. The Acetyl Chain segment includes the integrated chain of intermediate chemistry, emulsion polymers, ethylene vinyl acetate polymers, redispersible powders (RDP), and acetate tow businesses. Its intermediate chemistry business produces and supplies acetyl products, including acetic acid, vinyl acetate monomer, acetic anhydride and acetate esters. It also produces organic solvents and intermediates for pharmaceutical, agricultural and chemical products.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD 1.52B.%!(EXTRA int=2)
Undervalued
The company’s latest PB is 0.95, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 114.50M shares, decreasing 11.81% quarter-over-quarter.
Held by Van Duyn Dodge & E. Morris Cox
Star Investor Van Duyn Dodge & E. Morris Cox holds 15.32M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.62.

Financial Health

Currency: USD Updated2025-09-12

The company's current financial score is 6.52, which is lower than the Chemicals industry's average of 6.99. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 2.39B, representing a year-over-year decrease of 8.50%, while its net profit experienced a year-over-year decrease of 117.36%.

Score

Industry at a Glance

Previous score
6.52
Change
0

Financials

6.95

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

4.88

Operational Efficiency

7.60

Growth Potential

7.94

Shareholder Returns

5.23

Company Valuation

Currency: USD Updated2025-09-12

The company’s current valuation score is 1.20, which is lower than the Chemicals industry's average of 2.55. Its current P/E ratio is -3.18, which is -0.07% below the recent high of -3.18 and -15.32% above the recent low of -3.67.

Score

Industry at a Glance

Previous score
4.00
Change
0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 38/72
No Data

Earnings Forecast

Currency: USD Updated2025-09-12

The company’s current earnings forecast score is 6.56, which is lower than the Chemicals industry's average of 7.30. The average price target for Celanese Corp is 49.50, with a high of 78.12 and a low of 42.00.

Score

Industry at a Glance

Previous score
6.56
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 18 analysts
Hold
Current Rating
54.570
Target Price
+19.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

24
Total
4
Median
7
Average
Company name
Ratings
Analysts
Celanese Corp
CE
18
Albemarle Corp
ALB
28
Ecolab Inc
ECL
27
Eastman Chemical Co
EMN
19
Sociedad Quimica y Minera de Chile SA
SQM
15
Element Solutions Inc
ESI
11
1
2
3
4
5

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated2025-09-12

The company’s current price momentum score is 7.40, which is lower than the Chemicals industry's average of 8.17. Sideways: Currently, the stock price is trading between the resistance level at 55.11 and the support level at 38.09, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.77
Change
-0.06

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.397
Neutral
RSI(14)
43.764
Neutral
STOCH(KDJ)(9,3,3)
27.948
Neutral
ATR(14)
2.015
High Vlolatility
CCI(14)
-57.787
Neutral
Williams %R
80.889
Oversold
TRIX(12,20)
-0.274
Sell
StochRSI(14)
34.989
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
45.230
Sell
MA10
45.854
Sell
MA20
46.083
Sell
MA50
50.668
Sell
MA100
51.689
Sell
MA200
56.518
Sell

Institutional Confidence

Currency: USD Updated2025-09-12

The company’s current institutional recognition score is 10.00, which is higher than the Chemicals industry's average of 7.92. The latest institutional shareholding proportion is 104.65%, representing a quarter-over-quarter decrease of 4.34%. The largest institutional shareholder is Van Duyn Dodge & E. Morris Cox, holding a total of 15.32M shares, representing 13.99% of shares outstanding, with 12.34% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
15.39M
+13.02%
The Vanguard Group, Inc.
Star Investors
11.96M
-8.89%
BlackRock Institutional Trust Company, N.A.
11.96M
+117.93%
Federated MDTA LLC
1.78M
+9544.79%
Capital Research Global Investors
4.98M
+9.49%
Turtle Creek Asset Management Inc.
4.51M
+28.49%
State Street Global Advisors (US)
3.71M
-17.28%
Harris Associates L.P.
Star Investors
2.25M
+1.39%
Fuller & Thaler Asset Management Inc.
3.16M
+34.95%
Norges Bank Investment Management (NBIM)
8.50M
+163.99%
1
2

Risk Assessment

Currency: USD Updated2025-09-12

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Chemicals export-driven industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The company’s current risk assessment score is 3.07, which is lower than the Chemicals industry's average of 4.12. The company's beta value is 1.11. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
3.07
Change
0
Beta vs S&P 500 index
1.16
VaR
+3.57%
240-Day Maximum Drawdown
+73.19%
240-Day Volatility
+63.52%
Return
Best Daily Return
60 days
+8.84%
120 days
+17.10%
5 years
+17.10%
Worst Daily Return
60 days
-13.07%
120 days
-16.58%
5 years
-26.32%
Sharpe Ratio
60 days
-1.28
120 days
-0.32
5 years
-0.27
Risk Assessment
Maximum Drawdown
240 days
+73.19%
3 years
+78.19%
5 years
+78.43%
Return-to-Drawdown Ratio
240 days
-0.92
3 years
-0.22
5 years
-0.17
Skewness
240 days
-1.53
3 years
-1.47
5 years
-1.30
Volatility
Realised Volatility
240 days
+63.52%
5 years
+40.63%
Standardised True Range
240 days
+6.12%
5 years
+7.79%
Downside Risk-Adjusted Return
120 days
-41.04%
240 days
-41.04%
Maximum Daily Upside Volatility
60 days
+46.32%
Maximum Daily Downside Volatility
60 days
+54.02%
Liquidity
Average Turnover Rate
60 days
+1.84%
120 days
+2.40%
5 years
--
Turnover Deviation
20 days
+61.84%
60 days
+20.37%
120 days
+56.77%

Peer Comparison

Chemicals
Celanese Corp
Celanese Corp
CE
6.19 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Element Solutions Inc
Element Solutions Inc
ESI
7.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Perimeter Solutions Inc
Perimeter Solutions Inc
PRM
7.34 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ingevity Corp
Ingevity Corp
NGVT
7.19 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hawkins Inc
Hawkins Inc
HWKN
7.18 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Linde PLC
Linde PLC
LIN
7.17 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI